🇺🇸 FDA
Patent

US 10052374

Compositions, methods and uses for dengue virus serotype-4 constructs

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10052374 (Compositions, methods and uses for dengue virus serotype-4 constructs) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/575